Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
Express Scripts
Julphar
UBS
McKesson
Cerilliant
Colorcon
Healthtrust

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009631

« Back to Dashboard

NDA 009631 describes HISERPIA, which is a drug marketed by Bowman Pharms and is included in one NDA. Additional details are available on the HISERPIA profile page.

The generic ingredient in HISERPIA is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Summary for 009631
Tradename:HISERPIA
Applicant:Bowman Pharms
Ingredient:reserpine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 009631

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.25MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cipla
Dow
Johnson and Johnson
Merck
Covington
Fish and Richardson
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.